황산바륨

Barium Sulfate

원료 코드 M040801 국내 제품 1개 (단일제 1 · 복합제 0) DUR 성분 D001385

🌐 미국 FDA 자료(영문 라벨·부작용 보고·리콜)가 있습니다. 한국어는 AI 번역 참고용이니 원문을 함께 확인하세요. 해외 정보 보기

⚠️ DUR 안전사용 기준

  • 🤰 임부금기 2등급 방사선 절차는 태아 기형 유발 가능(경구용현탁액제/현탁액용산제)

이 성분만 든 제품 (단일제 1)

🌐 해외(미국) 정보 — 황산바륨

미국 FDA·NLM 자료 · 2026-10-05 기준

이 성분은 한국어 번역이 없습니다(검수 전 자동 번역 게시는 멈춰 두었습니다). 아래는 미국 FDA 원문입니다 — 원문 라벨(DailyMed).

Radiographic Contrast Agent [EPC]

미국에서 쓰이는 곳(적응증)

영어 원문 (미국 FDA 라벨)

is indicated for modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR THIN HONEY is a radiopaque contrast agent indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients ( 1 )

쓰면 안 되는 경우

영어 원문 (미국 FDA 라벨)

is contraindicated in patients with: known or suspected perforation of the gastrointestinal (GI) tract known obstruction of the GI tract high risk of GI perforation such as those with a recent GI perforation, acute GI hemorrhage or ischemia, toxic megacolon, severe ileus, post GI surgery or biopsy, acute GI injury or burn, or recent radiotherapy to the pelvis high risk of aspiration such as those with known or suspected tracheo-esophageal fistula or obtundation known severe hypersensitivity to barium sulfate or any of the excipients of VARIBAR THIN HONEY Known or suspected perforation of the gastrointestinal (GI) tract ( 4 ) Known obstruction of the GI tract ( 4 ) Conditions associated with high risk of GI perforation or aspiration ( 4 ) Known hypersensitivity to barium sulfate or any of the excipients of VARIBAR THIN HONEY ( 4 )

주요 경고·주의

영어 원문 (미국 FDA 라벨)

Hypersensitivity reactions: Emergency equipment and trained personnel should be immediately available ( 5.1 ) Intra-abdominal leakage: May occur in conditions such as GI fistula, ulcer, inflammatory bowel disease, appendicitis or diverticulitis, severe stenosis or obstructing lesions of the GI tract ( 5.2 ) Delayed GI transit and obstruction: Patients should maintain adequate hydration in days following barium sulfate procedure to avoid obstruction or impaction ( 5.3 ) Aspiration Pneumonitis: Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration ( 5.4 ) 5.1 Hypersensitivity Reactions Barium sulfate preparations contain a number of excipients, including natural and artificial flavors and may induce serious hypersensitivity reactions. The manifestations include hypotension, bronchospasm and other respiratory impairments, and dermal reactions including rashes, urticaria and itching. A history of bronchial asthma, atopy, food allergies, or a previous reaction to a contrast agent may increase the risk for hypersensitivity reactions. Emergency equipment and trained personnel should be immediately available for treatment of a hypersensitivity reaction. 5.2 Intra-abdominal Barium Leakage The use of VARIBAR THIN HONEY is contraindicated in patients at high risk of perforation of the GI tract [see Contraindications ( 4 )] . Administration of VARIBAR THIN HONEY may result in leakage of barium from the GI tract in the presence of …

임신·특수 환자

영어 원문 (미국 FDA 라벨)

8.1 Pregnancy Risk Summary VARIBAR THIN HONEY is not absorbed systemically following oral administration, and maternal use is not expected to result in fetal exposure to the drug. 8.2 Lactation Risk Summary VARIBAR THIN HONEY is not absorbed systemically by the mother following oral administration, and breastfeeding is not expected to result in exposure of the infant to the drug. 8.4 Pediatric Use The efficacy of VARIBAR THIN HONEY in pediatric patients is based on successful opacification of the pharynx during modified barium swallow examinations [see Clinical Pharmacology ( 12.1 )] . Safety and dosing recommendations in pediatric patients are based on clinical experience. VARIBAR THIN …

미국 제품명 Varibar Thin Honey, Varibar Pudding, Varibar Nectar, ENTERO Vu 24%, E-Z-Paque, Tagitol V, Varibar Thin Liquid, E-Z-HD, Readi-Cat 2 Berry Smoothie, Readi-Cat 2 Banana Smoothie, Readi-Cat 2, Readi-Cat 2 Creamy Vanilla Smoothie

미국 부작용 보고(FAERS)에 많이 나온 증상

미국 FDA에 접수된 이 성분 관련 보고 434건 가운데 많이 적힌 증상입니다. 보고 수는 약 때문이라는 증거가 아니며, 많이 쓰는 약일수록 많아집니다. 증상 이름의 한국어는 AI 번역(참고용)이라 영어 원어를 함께 적었습니다.

  1. 1 ASPIRATION69
  2. 2 이상반응 없음no adverse event35
  3. 3 URTICARIA28
  4. 4 설사diarrhoea27
  5. 5 소양증pruritus19
  6. 6 급성 신장 손상acute kidney injury18
  7. 7 호흡 곤란dyspnoea18
  8. 8 신부전renal failure18
  9. 9 구토vomiting17
  10. 10 만성 신장병chronic kidney disease15
  11. 11 발진rash15
  12. 12 기침cough14

미국 리콜 기록

FDA 리콜(회수) 기록 3건 중 최근 3건 — 특정 회사·제조번호 제품의 회수로, 국내 제품과는 관계없을 수 있습니다.

  • 2022.06.15 · 2등급 · Mckesson Medical-Surgical Inc. Corporate Office cGMP deviations: Temperature abuse
  • 2018.04.04 · 2등급 · Bracco Diagnostics Inc. Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.
  • 2014.08.20 · 3등급(경미) · Bracco Diagnostic Inc Subpotent Drug: Low out of specification results for both pH and assay obtained during routine stability testing after 36 months.

출처: 미국 FDA openFDA(라벨·FAERS·리콜), 미국 국립의학도서관 RxNorm · DailyMed 원문 라벨. 한국어는 오픈드럭 서버 AI(gemma)가 자동 번역한 참고용(사람 검수 전)으로 오역이 있을 수 있으니 반드시 원문을 확인하세요.